137 related articles for article (PubMed ID: 1933904)
21. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
Wiman KG
Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
[TBL] [Abstract][Full Text] [Related]
22. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.
Tamura G; Kihana T; Nomura K; Terada M; Sugimura T; Hirohashi S
Cancer Res; 1991 Jun; 51(11):3056-8. PubMed ID: 2032245
[TBL] [Abstract][Full Text] [Related]
23. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
[TBL] [Abstract][Full Text] [Related]
24. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
25. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the p53 gene are not detectable in human testicular tumors.
Fleischhacker M; Strohmeyer T; Imai Y; Slamon DJ; Koeffler HP
Mod Pathol; 1994 May; 7(4):435-9. PubMed ID: 8066072
[TBL] [Abstract][Full Text] [Related]
27. p53 protects against skin cancer induction by UV-B radiation.
Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
[TBL] [Abstract][Full Text] [Related]
28. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
29. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
[TBL] [Abstract][Full Text] [Related]
31. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
32. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
Adesina AM; Nalbantoglu J; Cavenee WK
Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
[TBL] [Abstract][Full Text] [Related]
33. Genome instability in secondary solid tumors developing after radiotherapy of bilateral retinoblastoma.
Lefèvre SH; Vogt N; Dutrillaux AM; Chauveinc L; Stoppa-Lyonnet D; Doz F; Desjardins L; Dutrillaux B; Chevillard S; Malfoy B
Oncogene; 2001 Dec; 20(56):8092-9. PubMed ID: 11781822
[TBL] [Abstract][Full Text] [Related]
34. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
[TBL] [Abstract][Full Text] [Related]
35. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
[TBL] [Abstract][Full Text] [Related]
36. Infrequent p53 gene mutations in medulloblastomas.
Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms for inactivation of tumor suppressor genes].
Ishizaki K
Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M
Leukemia; 1994 May; 8(5):758-67. PubMed ID: 8182933
[TBL] [Abstract][Full Text] [Related]
39. The p53 tumor suppressor gene of the marsupial Monodelphis domestica: cloning of exons 4-11 and mutations in exons 5-8 in ultraviolet radiation-induced corneal sarcomas.
Kusewitt DF; Sherburn TE; Miska KB; Tafoya GB; Gale JM; Miller RD
Carcinogenesis; 1999 Jun; 20(6):963-8. PubMed ID: 10357774
[TBL] [Abstract][Full Text] [Related]
40. Analysis of a metastasizing testicular mixed gonadal stromal tumor with osteosarcoma components suggests that a malignant tumor with the histology of osteosarcoma may develop without primary involvement of RB1 and TP53.
Reuvekamp PT; Stulp RP; Schraffordt Koops H; Oosterhuis JW; Scheffer H; Buys CH
Cancer Res; 1992 Dec; 52(23):6705-7. PubMed ID: 1423318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]